Medtronic (MDT) Accumulated Expenses (2014 - 2026)

Medtronic has disclosed Accumulated Expenses across 13 years of filings, most recently posting $2.6 billion for Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $2.6 billion, up 13.15% year-over-year; the trailing twelve-month figure through Jan 2026 was $2.6 billion (up 13.15% YoY), and the FY2025 annual result was $2.5 billion, up 5.85% from the prior year.
• Accumulated Expenses came in at $2.6 billion for Q1 2026 at Medtronic, up from $2.1 billion in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $2.6 billion in Q1 2026 to a low of $1.7 billion in Q3 2023.
• The 5-year median for Accumulated Expenses is $2.0 billion (2025), against an average of $2.1 billion.
• Across the five-year window, Accumulated Expenses retreated 14.54% in 2022 and advanced 21.86% in 2024, its largest moves.
• Medtronic's Accumulated Expenses stood at $1.7 billion in 2022, then increased by 2.15% to $1.8 billion in 2023, then gained by 7.68% to $1.9 billion in 2024, then rose by 12.52% to $2.1 billion in 2025, then advanced by 21.17% to $2.6 billion in 2026.
• The last three Accumulated Expenses figures came in at $2.6 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.0 billion (Q3 2025), per Business Quant data.